Clinical Trial Update: Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy results for OpRegen in advanced dry age-related macular degeneration from a Phase 1/2 study (results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• OpRegen

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-03-06